Binding of the radiolabeled glycine site antagonist [3H]MDL 105,519 to homomeric NMDA-NR1a receptors

European Journal of Pharmacology

Volumn 312, Issue 3, 1996, Pages 357-365

  Siegel, Barry W ^a   Sreekrishna, Koti ^a   Baron, Bruce M ^a  

^a SANOFI   (France)

Author keywords

Binding; Glycine; NMDA receptor; 3H MDL 105,519

Indexed keywords

3 (2 CARBOXY 2 PHENYLETHENYL) 4,6 DICHLORO 1H INDOLE 2 CARBOXYLIC ACID; 6,7 DICHLORO 5 NITRO 2,3 QUINOXALINEDIONE; 7 CHLORO 4 HYDROXY 3 (3 PHENOXYPHENYL) 2 QUINOLONE; GLYCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SERINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CHO CELL; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL;

EID: 0030567961     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00477-3     Document Type: Article

References (34)

1. 2-adrenergic receptors, Mol. Pharmacol. 38, 348.
2. 3H]5,7-Dichlorokynurenic acid, a novel radioligand labels NMDA receptor-associated glycine binding sites, Eur. J. Pharmacol. 206, 149.
3. 3H]-MDL105,519, a high affinity radioligand for the NMDA receptor-associated glycine recognition site, J. Pharmacol. Exp. Ther. (in press).
4. Boeckman, F.A. and E. Aizenman, 1994, Stable transfection of the NR1 subunit in Chinese hamster ovary cells fails to produce a functional N-methyl-D-aspartate receptor, Neurosci. Lett. 173, 189.
5. Bradford, M., 1976, A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72, 248.
6. Chazot, P.L., M. Cik and F.A. Stephenson, 1992, Immunological detection of the NMDAR1 glutamate receptor subunit expressed in human embryonic kidney 293 cells and in brain, J. Neurochem. 59, 1176.
7. Grimwood, S., G.J.C. Wilde and A.C. Foster, 1993, Interactions between the glutamate and glycine recognition sites of the N-methyl-D-aspartate receptor from rat brain, as revealed from radioligand binding studies, J. Neurochem. 60, 1729.
8. Grimwood, S., B. Le Bourdelles and P.J. Whiting, 1995a, Recombinant human NMDA homomeric NR1 receptors expressed in mammalian cells form a high-affinity glycine antagonist binding site, J. Neurochem. 64, 525.
9. +2-influx assay, Soc. Neurosci, 21, Abstr, 499,3.
10. Hasegawa, Y., M. Fisher, B.M. Baron and G. Metcalf, 1994, The competitive NMDA antagonist MDL 100,453 reduces infarct size after experimental stroke, Stroke 25, 1241.
11. Hollmann, M. and S. Heinemann, 1994, Cloned glutamate receptors, Annu. Rev. Neurosci, 17, 31.
12. Ishii, T., K. Moriyoshi, H. Sugihara, K. Sakurada, H. Kadotani, M. Yokoi, C. Akazawa, R. Shigemoto, N. Mizuno, M. Masu and S. Nakanishi, 1993, Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits, J. Biol. Chem. 268, 2836.
13. Karp, S.J., M. Masu, T. Eki, K. Ozawa and S. Nakanishi, 1993, Molecular cloning and chromosomal localization of the key subunit of the human N-methyl-D-aspartate receptor, J. Biol. Chem. 268, 3728.
14. Kehne, J.H., B.M. Baron, B.L. Harrison, T.C. McCloskey, M.G. Palfreyman, M. Poirot, F.G. Salituro, B.W. Siegel, A.L. Slone, P.L.M. Van Giersberger and H.S. White, 1995, MDL 100,458 and MDL 102,288: two potent and selective glycine antagonists with different functional profiles, Eur. J. Pharmacol. 284, 109.
15. Kulagowski, J.J., R. Baker, N.R. Curtis, P.D. Leeson, I.M. Mawer, A.M. Moseley, M.P. Ridgill, M. Rowley, I. Stansfield, A.C. Foster, S. Grimwood, R.G. Hill, J.A. Kemp, G.R. Marshall, K.L. Saywell and M.D. Tricklebank, 1994, 3′-(Arylmethy1)-and 3′-(aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H )-ones: orally active antagonists of the glycine site on the NMDA receptor, J. Med. Chem. 37, 1402.
16. Kuryatov, A., B. Laude, H. Betz and J. Kuhse, 1994, Mutational analysis of the glycine-binding site of the NMDA receptor: structural similarity with bacterial amino acid-binding proteins, Neuron 12, 1291.
17. Kuusinen, A., M. Arvola and K. Keinanen, 1995, Molecular dissection of the agonist binding site of the AMPA receptor, EMBO J. 14, 6327.
18. Laurie, D.J. and P.H. Seeburg, 1994, Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition, Eur. J. Pharmacol. 268, 335.
19. Limbird, L.E., 1986, Cell Surface Receptors: a Short Course on Theory and Methods (Martinus Nijhoff Publishing, Boston).
20. Lipton, S.A. and P.A. Rosenberg, 1994, Excitatory amino acids as a common final pathway for neurologic disorders, New. Engl. J. Med. 330,613.
21. Maniatis, T., E.F. Fritsch and J. Sambrook, 1982, Molecular Cloning: a Laboratory Manual (Cold Spring Harbor Laboratory).
22. Monaghan, D.T., H.J. Oliverman, L. Nguyen, J.C. Watkins and C.W. Cotman, 1988, Two classes of N-methyl-D-aspartate recognition sites: differential distribution and differential regulation by glycine, Proc. Natl. Acad. Sci. 85, 9836.
23. Moriyoshi, K., M. Masu, T. Ishii, R. Shigemoto, N. Mizuno and S. Nakanishi, 1991, Molecular cloning and characterization of the rat NMDA receptor, Nature 354, 31.
24. Muir, K.W. and K.R. Lees, 1995, Clinical experience with excitatory amino acid antagonist drugs, Stroke 26, 503.
25. Nakanishi, S., 1992, Molecular diversity of the glutamate receptors and implications for brain function, Science 258, 597.
26. Orstein, P.L., M.B. Arnold, N.K. Allen, J.D. Leander, J.P. Tizzano, D. Lodge and D. Schoepp, 1995, (3SR,4a RS,6SR,8a RS)-6-(1H-Tetrazol-5-yl)decahydroisoquinoline-3-carboxylic acid, a novel, competitive, systemically active NMDA and AMPA receptor antagonist, J. Med. Chem, 38, 4885.
27. Priestley, T., P. Laughton, J. Myers, B. LeBourdelles, J. Kerby and P.J. Whiting, 1995, Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/ND2B subunit assemblies expressed in permanently transfected mouse fibroblast cells, Mol. Pharmacol. 48, 841.
28. Seeburg, P.H., N. Burnashev, G. Kohr, T. Kumer, R. Sprengel and H. Monyer, 1995, The NMDA receptor channel: molecular design of a coincidence detector, Rec. Prog. Hormone Res. 50, 19.
29. Stern-Bach, Y., B. Bernhard, M. Hartley, P.O. Sheppard, P.J. O'Hara and S.F. Heinemann, 1994, Agonist selectivity of glutamate receptors is specified by two domains structurally related to bacterial amino-acid-binding proteins, Neuron 13, 1345 .
30. Sugihara, H., K. Moriyoshi, T. Ishii, M. Masu and S. Nakanishi, 1992, Structures and properties of seven isoforms of the NMDA receptor generated by alternative splicing, Biochem. Biophys. Res. Commun. 185, 826.
31. Wafford, K.A., M. Kathoria, C.J. Bain, G. Marshall, B. LeBourdelles, J.A. Kemp and P.J. Whiting, 1995, Identification of amino acids in the N-methyl-D-aspartate receptor NR1 subunit that contribute to the glycine binding site, Mol. Pharmacol. 47, 374.
32. Warner, D.S., H. Martin, P. Ludwig, A. McAllister, J.F.W. Keana and E. Weber, 1995. In vivo models of cerebral ischemia: effects of parentally administered NMDA receptor glycine site antagonists, J. Cerebral Blood Flow Metab. 15, 188.
33. Woodward, R.M., J.E. Huettner, J. Guastella, J.F.W. Keana and E. Weber, 1995, In vitro pharmacology of ACEA-1021 and ACEA-1031: systematically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites, Mol. Pharmacol. 47, 568.
34. Zukin, R.S. and M.V.L. Bennett, 1995, Alternatively spliced isoforms of the NMDAR1 receptor subunit, Trends Neurosci. 18, 289.